If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 7, November 2011

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites
Favourites:Add to Favourites

Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
pp. 766-776(11)
Authors: Siciliano, Raffaella; Barone, Eugenio; Calabrese, Vittorio; Rispoli, Vincenzo; Allan Butterfield, D.; Mancuso, Cesare

Favourites:Add to Favourites

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders
pp. 777-791(15)
Authors: Pierucci, Massimo; Galati, Salvatore; Valentino, Mario; Di Matteo, Vincenzo; Benigno, Arcangelo; Pitruzzella, Alessandro; Muscat, Richard; Di Giovanni, Giuseppe

Favourites:Add to Favourites

Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
pp. 792-807(16)
Authors: Bernstein, Hans-Gert; Keilhoff, Gerburg; Steiner, Johann; Dobrowolny, Henrik; Bogerts, Bernhard

Favourites:Add to Favourites

Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
pp. 808-819(12)
Authors: Banach, Monika; Piskorska, Barbara; J. Czuczwar, Stanislaw; K. Borowicz, Kinga

Favourites:Add to Favourites

Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors
pp. 820-833(14)
Authors: P. Fernandez, Ana; Serrano, Julia; A. Amorim, Miguel; Pozo-Rodrigalvarez, Andrea; Martinez-Murillo, Ricardo

Favourites:Add to Favourites

Meta-Analysis of the Effectiveness and Safety of Prophylactic Use of Nimodipine in Patients with an Aneurysmal Subarachnoid Haemorrhage
pp. 834-844(11)
Authors: Jian Liu, Guang; Luo, Jie; Ping Zhang, Li; Jun Wang, Zheng; Li Xu, Li; Hou He, Guo; Jun Zeng, Yan; Fu Wang, Yun

Favourites:Add to Favourites

Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
pp. 845-848(4)
Authors: Shakil, Shazi; Khan, Rosina; Tabrez, Shams; Alam, Qamre; R. Jabir, Nasimudeen; I. Sulaiman, Mansour; H. Greig, Nigel; A. Kamal, Mohammad

Favourites:Add to Favourites

Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
pp. 849-862(14)
Authors: Foti Cuzzola, V.; Ciurleo, R.; Giacoppo, S.; Marino, S.; Bramanti, P.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more